For Providers

As one of the longest-standing thalassemia care centers in the country, we possess extensive experience and treatment expertise. The Weill Cornell Medicine New York Comprehensive Thalassemia Center is trusted to provide up-to-date guidelines as well as support for hematologists and primary care providers. We also have a rich history of participating in and conducting clinical trials, resulting in major care advancements in care and outcome improvements through a reduction in morbidity. 


Guidelines developed at the New York Comprehensive Thalassemia Center, based on review of available literature and our own experience, include:

  • Guidelines for Transfusion-Dependent Thalassemia (TDT) Transfusion Therapy
  • Guidelines for Comprehensive Thalassemia Monitoring
  • Guidelines for Thalassemia Chelation (Transfusion-Dependent and Non-Transfusion-Dependent Patients)
  • Guidelines for Thalassemia Patient Pregnancy Management

Open Clinical Trials

Weill Cornell Thalassemia Clinical Trials

View and participate in ongoing clinical trials at the New York Comprehensive Thalassemia Center.

New York Comprehensive Thalassemia Center of Weill Cornell Medicine 525 E. 68th St.
Payson 695
New York, NY 10065 Phone: (212) 746-3400